A critical role for the Sp1-binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase gene expression in macrophages

Nucleic Acids Research

Volumn 33, Issue 5, 2005, Pages 1423-1434

  Irvine, Scott A ^a   Foka, Pelagia ^a   Rogers, Sarah A ^a   Mead, James R ^a,b   Ramji, Dipak P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOPROTEIN LIPASE; MESSENGER RNA; POLYPEPTIDE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA; DNA BINDING PROTEIN; SP3 PROTEIN, HUMAN; SP3 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; STEADY STATE; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPROTEIN LIPASE; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 14844367135     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki280     Document Type: Article

References (55)

1. Mead,J.R., Irvine,S.A. and Ramji,D.P. (2002) Lipoprotein lipase: structure, function, regulation and role in disease. [i#J. Mol. Med.#1i], [b#80#1b], 753-769.
2. Mead,J.R. and Ramji,D.P. (2002) The pivotal role of lipoprotein lipase in atherosclerosis. [i#Cardiovasc. Res.#1i], [b#55#1b], 261-269.
3. O'Brien,K.D., Gordon,D., Deeb,S., Ferguston,M. and Chait,A. (1992) Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. [i#J. Clin. Invest.#1i], [b#89#1b] 1544-1550.
4. Renier,G., Skamene,E., DeSanctis,J.B. and Radzioch,D. (1993) High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. [i#Arterioscler. Thromb.#1i], [b#13#1b], 190-196.
5. Sartippour,M.R. and Renier,G. (2000) Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: Role of peripheral factors. [i#Diabetes#1i], [b#49#1b], 597-602.
6. Beauchamp,M.-C., Letendre,E. and Renier,G. (2002) Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia. [i#J. Lipid Res.#1i], [b#43#1b], 215-222.
7. Babaev,V.R., Fazio,S., Gleaves,L.A., Carter,K.J., Semenkovich,C.F. and Linton,M.F. (1999) Macrophage LPL promotes foam cell formation and atherosclerosis [i#in vivo. J. Clin. Invest.#1i], [b#103#1b], 1697-1705.
8. Babaev,V.R., Patel,M.B., Semenkovich,C.F., Fazio,S. and Linton,M.F. (2000) Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. [i#J. Biol. Chem.#1i], [b#275#1b], 26293-26299.
9. Van Eck,M., Zimmermann,R., Groot,P.H., Zechner,R. and Van Berkel,T.J. (2000) Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. [i#Arterioscler. Thromb. Vasc. Biol.#1i], [b#20#1b], 53-62.
10. Wilson,K., Fry,G.L., Chappell,D.A., Sigmund,C.D. and Medh,J.D. (2001) Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein E knockout mice but not in C57BL/6 mice. [i#Arterioscler. Thromb. Vasc. Biol.#1i], [b#21#1b], 1809-1815.
11. Panousis,C.G., Evans,G. and Zuckerman,S.H. (2001) TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: Opposing the effects of IFN-γ. [i#J. Lipid Res.#1i], [b#42#1b], 856-863.
12. Argmann,C.A., Van Den Diepstraten,C.H., Sawyez,C.G., Edwards,J.Y., Hegele,R.A., Wolfe,B.M. and Huff,M.W. (2001) Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. [i#Arterioscler. Thromb. Vasc. Biol.#1i] [b#21#1b], 2011-2018.
13. Bottalico,L.A., Wager,R.E., Agellon,L.B., Assoian,R.K. and Tabas,I. (1991) Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. [i#J. Biol. Chem.#1i], [b#266#1b], 22866-22871.
14. Draude,G. and Lorenz,R.L. (2000) TGF-β1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. [i#Am. J. Physiol. Heart Circ. Physiol.#1i], [b#278#1b], H1042-H1048.
15. Shull,M.M., Ormsby,I., Kier,A.B., Pawlowski,S., Diebold,R.L., Yin,M., Allen,R., Sidman,C., Proetzel,G., Calvin,D., Annunziata,N. and Doetschman,T. (1992) Targeted disruption of mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. [i#Nature#1i] [b#359#1b], 693-699.
16. Edwards,D.R., Murphy,G., Reynolds,J.J., Whitman,S.E., Dochertt,A.J., Angel,P. and Heath,J.K. (1987) Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. [i#EMBO J.#1i], [b#6#1b], 1899-1904.
17. Ding,A., Nathan,C.F., Graycar,J., Derynk,R., Stuehr,D.J. and Srimal,S. (1990) Macrophage deactivating factor and transforming growth factor-β1, -β2 and -β3 inhibit induction of macrophage nitric oxide synthesis by IFN-γ. [i#J. Immunol.#1i], [b#145#1b], 940-944.
18. Di Febbo,C., Baccante,G., Reale,M., Castellani,M.L., Angelini,A., Cuccurullo,F. and Porreca,E. (1998) Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells. [i#Atherosclerosis#1i], [b#136#1b], 377-382.
19. Mallat,Z., Gojova,A., Marchiol-Fournigault,C., Esposito,B., Kamate,C., Merval,R., Fradelizi,D. and Tedgui,A. (2001) Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. [i#Circ. Res.#1i], [b#89#1b], 930-934.
20. Reckless,J., Metcalf,J. and Grainger,D.J. (1997) Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. [i#Circulation#1i], [b#95#1b], 1542-1548.
21. Lutgens,E., Cleutjens,K.B., Heeneman,S., Koteliansky,V.E., Burkly,L.C. and Daemen,M.J. (2000) Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. [i#Proc. Natl Acad. Sci. USA#1i], [b#97#1b], 7464-7469.
22. Stefoni,S., Cianciolo,G., Donati,G., Dormi,A., Silvestri,M.G., Coli,L., Pascalis,A.D. and Lannelli,S. (2002) Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. [i#Kidney Int.#1i], [b#61#1b], 324-335.
23. Robertson,A.K., Rudling,M., Zhou,X., Gorelik,L., Flavell,R.A. and Hansson,G.K. (2003) Disruption of TGF-β signaling in T cells accelerates atherosclerosis. [i#J. Clin. Invest.#1i], [b#112#1b], 1342-1350.
24. Derynck,R and Zhang,Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. [i#Nature#1i], [b#425#1b], 577-584.
25. Shi,Y. and Massague,J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. [i#Cell#1i], [b#113#1b], 685-700.
26. Hughes,T.R., Tengku-Muhammad,T.S., Irvine,S.A. and Ramji,D.P. (2002) A novel role of Sp1 and Sp3 in the interferon-γ-mediated suppression of macrophage lipoprotein lipase gene transcription. [i#J. Biol. Chem.#1i], [b#277#1b], 11097-11106.
27. Tengku-Muhammad,T.S., Hughes,T.R., Cryer,A. and Ramji,D.P. (1996) Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines. [i#Cytokine#1i], [b#8#1b], 525-533.
28. Tengku-Muhammad,T.S., Cryer,A. and Ramji,D.P. (1998) Synergism between IFN-γ and TNF-α in the regulation of lipoprotein lipase in the macrophage J774.2 cell line. [i#Cytokine#1i], [b#10#1b], 38-48.
29. Mead,J.R., Hughes,T.R., Irvine,S.A., Singh,N.N. and Ramji,D.P. (2003) Interferon-γ stimulates the expression of the inducible cAMF early repressor in macrophages through the activation of casein kinase 2: A potentially novel pathway for IFN-γ-mediated inhibition of gene transcription. [i#J. Biol. Chem.#1i], [b#278#1b], 17741-17751.
30. Foka,P., Irvine,S.A., Kockar,F. and Ramji,D.P. (2003) Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-α gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. [i#Nucleic Acids Res.#1i], [b#31#1b], 6722-6732.
31. Kousteni,S., Kockar,F.T., Sweeney,G.E. and Ramji,D.P. (1998) Characterisation and developmental regulation of the [i#Xenopus laevis#1i] CCAAT-enhancer binding protein-β gene. [i#Mech. Dev.#1i], [b#77#1b], 143-148.
32. Hildebrandt,A.L. and Neufer,P.D. (2000) Exercise attenuates the fasting-induced transcriptional activation of metabolic genes in skeletal muscle. [i#Am. J. Physiol.#1i], [b#278#1b], E1078-E1086.
33. Duque,M., Graupner,M., Stutz,H., Wicher,I., Zechner,R., Paltauf,F. and Hermetter,A. (1996) New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimination of lipase activities. [i#J. Lipid Res.#1i], [b#37#1b], 868-876.
34. Gimble,J.M., Hua,X., Wanker,F., Morgan,C., Robinson,C., Hill,M.R and Nadon,N. (1995) [i#In vitro#1i] and [i#in vivo#1i] analysis of murine lipoprotein lipase gene promoter: Tissue-specific expression. [i#Am. J. Physiol.#1i], [b#268#1b], E213-E218.
35. Kockar,F.T., Foka,P., Hughes,T.R., Kousteni,S. and Ramji,D.P. (2001) Analysis of the [i#Xenopus laevis#1i] CCAAT-enhancer binding protein α gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1. [i#Nucleic Acids Res.#1i], [b#29#1b], 362-372.
36. Inaba,T., Kawamura,M., Gotoda,T., Harada,K., Shimada,M., Ohsuga,J., Shimano,H., Akanuma,Y., Yazaki,Y. and Yamada,N. (1995) Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages. [i#Arterioscler. Thromb. Vasc. Biol.#1i] [b#15#1b], 522-528.
37. Wrana,J.L., Attisano,L., Carcamo,J., Zentella,A., Doody,J., Laito,M., Wang,X.-F. and Massague,J. (1992) TGF-β signals through a heteromeric protein kinase receptor complex. [i#Cell#1i], [b#71#1b], 1003-1014.
38. Kennett,S.B., Udvadia,A.J. and Horowitz,J.M. (1997) Sp3 encodes multiple proteins that differ in the capacity to stimulate or repress transcription. [i#Nucleic Acids Res.#1i], [b#25#1b], 3110-3117.
39. Philipsen,S. and Suske,G. (1999) A tale of three fingers: The family of mammalian Sp/XKLF transcription factors. [i#Nucleic Acids Res.#1i], [b#27#1b] 2991-3000.
40. Jinnin,M., Ihn,H., Asano,Y., Yamane,K., Trojanowska,M. and Tamaki,K. (2004) Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. [i#Oncogene#1i], [b#23#1b] 1656-1667.
41. Law,A.K., Gupta,D., Levy,S., Wallace,D.C., McKeon,R.J. and Buck,C.R. (2004) TGF-β1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors. [i#BMC Neurosci.#1i], [b#5#1b], 1.
42. Botella,L.M., Sanchez-Elsner,T., Rius,C., Corbi,A. and Bernabeu,C. (2001) Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation. [i#J. Biol. Chem.#1i], [b#276#1b], 34486-34494.
43. Inagaki,Y., Nemoto,T., Nakao,A., Dijke,P.T., Kobayashi,K., Takehara,K. and Greenwel,P. (2001) Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2 (I) collagen gene transcription. [i#J. Biol. Chem.#1i], [b#276#1b], 16573-16579.
44. Feng,X.H., Lin,X. and Derynck,R. (2000) Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15 (Ink4B) transcription in response to TGF-β. [i#EMBO J.#1i], [b#19#1b], 5178-5193.
45. Park,I.K., Lyu,M.A., Yeo,S.J., Han,T.H. and Kook,Y.H. (2000) Sp1 mediates constitutive and transforming growth factor-β-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells. [i#Biochim. Biophys. Acta#1i], [b#1470#1b] 302-310.
46. Kang,Y., Chen,C.-R. and Massagué,J. (2003) A self-enabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for [i#Idl#1i] repression in epithelial cells. [i#Mol. Cell#1i] [b#11#1b], 915-926.
47. Comijn,J., Berx,G., Vermassen,P., Verschueren,K., van Grunsven,L., Bruyneel,E., Mareel,M., Huylebroeck,D. and van Roy,F. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. [i#Mol. Cell#1i], [b#7#1b], 1267-1278.
48. Pellacani,A., Wiesel,P., Razavi,S., Vasilj,V., Feinberg,M.W., Chin,M.T., Reeves,R. and Perrella,M.A. (2001) Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-β1. [i#J. Biol. Chem.#1i], [b#276#1b], 1653-1659.
49. Chadjichristos,C., Ghayor,C., Herrouin,J.-F., Ala-Kokko,L., Suske,G., Pujol,J.-P. and Galéra,P. (2002) Down-regulation of human type II collagen gene expression by transforming growth factor-β1 (TGF-β1) in articular chondrocytes involves SP3/SP1 ratio. [i#J. Biol. Chem.#1i], [b#277#1b], 43903-43917.
50. Ammanamanchi,S. and Brattain,M.G. (2001) Sp3 is a transcriptional repressor of transforming growth factor-β receptors. [i#J. Biol. Chem.#1i] [b#276#1b], 3348-3352.
51. Alliston,T., Choy,L., Ducy,P., Karsenty,G. and Derynck,R. (2001) TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. [i#EMBO J.#1i], [b#20#1b], 2254-2272.
52. Liu,D., Black,B.L. and Derynck,R. (2001) TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. [i#Genes Dev.#1i], [b#15#1b], 2950-2966.
53. Choy,L. and Derynck,R. (2003) Transforming growth factor-β inhibits adipocyte differentiation by Smad3 interacting with CCAAT/ enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. [i#J. Biol. Chem.#1i], [b#278#1b], 9609-9619.
54. Yang,W.-S. and Deeb,S.S. (1998) Sp1 and Sp3 transactivate the human lipoprotein lipase gene promoter through binding to a CT element: synergy with the sterol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant. [i#J. Lipid Res.#1i], [b#39#1b], 2054-2064.
55. Ulloa,L., Doody,J. and Massagué,J. (1999) Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. [i#Nature#1i], [b#397#1b], 710-713.